Asad Bashey

12.4k total citations · 1 hit paper
162 papers, 3.5k citations indexed

About

Asad Bashey is a scholar working on Hematology, Oncology and Immunology. According to data from OpenAlex, Asad Bashey has authored 162 papers receiving a total of 3.5k indexed citations (citations by other indexed papers that have themselves been cited), including 127 papers in Hematology, 61 papers in Oncology and 43 papers in Immunology. Recurrent topics in Asad Bashey's work include Hematopoietic Stem Cell Transplantation (97 papers), Acute Myeloid Leukemia Research (42 papers) and Acute Lymphoblastic Leukemia research (26 papers). Asad Bashey is often cited by papers focused on Hematopoietic Stem Cell Transplantation (97 papers), Acute Myeloid Leukemia Research (42 papers) and Acute Lymphoblastic Leukemia research (26 papers). Asad Bashey collaborates with scholars based in United States, United Kingdom and Germany. Asad Bashey's co-authors include Scott R. Solomon, Lawrence E. Morris, H. Kent Holland, Stacey Brown, Xu Zhang, Connie A. Sizemore, Melhem Solh, C. J. Marshall, Lyn Healy and Edward D. Ball and has published in prestigious journals such as Journal of Clinical Oncology, Blood and Stem Cells.

In The Last Decade

Asad Bashey

153 papers receiving 3.5k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Myeloablative Versus Reduced-Intensity Hematopoietic Cell Transplantation for Acute Myeloid Leukemia and Myelodysplastic Syndromes

2017 400 citations Steven M. Devine, Mehdi Hamadani et al. Journal of Clinical Oncology profile →

Peers

Countries citing papers authored by Asad Bashey

Since Specialization

Citations

This map shows the geographic impact of Asad Bashey's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Asad Bashey with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Asad Bashey more than expected).

Fields of papers citing papers by Asad Bashey

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Asad Bashey. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Asad Bashey. The network helps show where Asad Bashey may publish in the future.

Co-authorship network of co-authors of Asad Bashey

This figure shows the co-authorship network connecting the top 25 collaborators of Asad Bashey. A scholar is included among the top collaborators of Asad Bashey based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Asad Bashey. Asad Bashey is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Soluble urokinase plasminogen activator receptor and acute kidney injury in hematopoietic cell transplantation 2025 ·Blood Advances ·Bhavna Bhasin, Tao Wang, John E. Levine, Shalini Shenoy, Miguel‐Angel Perales, Asad Bashey, Hershel Raff, Wael Saber	0
2	Prophylactic Corticosteroids Allow Safe Outpatient Administration of Axicabtagene Ciloleucel with Comparable Toxicities to Other CAR-T Therapies in Large Cell Lymphoma 2024 ·Blood ·Steven Andrew Baker, Asad Bashey, Lizamarie Bachier‐Rodriguez, Lawrence E. Morris, H. Kent Holland, (unknown), Scott R. Solomon, Melissa Sanacore, Melhem Solh	0
3	Impact of Graft-Versus-Host Disease on Relapse and Nonrelapse Mortality Following Posttransplant Cyclophosphamide-Based Transplantation 2024 ·Transplantation and Cellular Therapy ·Scott R. Solomon, Lizamarie Bachier‐Rodriguez, Asad Bashey, Xu Zhang, Katelin C Jackson, H. Kent Holland, Lawrence E. Morris, Melhem Solh	1
4	Intrathecal Chemotherapy As Treatment for Chimeric Antigen Receptor T Cell (CAR T) Therapy Associated Neurotoxicity 2023 ·Blood ·Melhem Solh, Asad Bashey, Lawrence E. Morris, Lizamarie Bachier‐Rodriguez, H. Kent Holland, Xu Zhang, Katelin C Jackson, Scott R. Solomon	1
5	Allogeneic Hematopoietic Cell Transplantation (HCT) for Adult Patients with Acute Lymphoblastic Leukemia: Impact of Timely Transplantation on Survival Outcomes 2022 ·Transplantation and Cellular Therapy ·Melhem Solh, Asad Bashey, H. Kent Holland, Lawrence E. Morris, Scott R. Solomon	1
6	Lineage-Specific Relapse Prediction After Haploidentical Transplantation With Post-Transplant Cyclophosphamide Based on Recipient HLA-B-Leader Genotype and HLA-C-Group KIR Ligand 2022 ·Transplantation and Cellular Therapy ·Scott R. Solomon, Michael T. Aubrey, Xu Zhang, Katelin C Jackson, Christina L. Roark, Brian M. Freed, Lawrence E. Morris, H. Kent Holland, Melhem Solh, Asad Bashey	9
7	Extracorporeal photopheresis (ECP) improves overall survival in the treatment of steroid refractory acute graft-versus-host disease (SR aGvHD) 2022 ·Bone Marrow Transplantation ·Melhem Solh, (unknown), Scott R. Solomon, Asad Bashey, Lawrence E. Morris, H. Kent Holland, Xu Zhang	3
8	Allogeneic blood or marrow transplantation with haploidentical donor and post-transplantation cyclophosphamide in patients with myelofibrosis: a multicenter study 2021 ·Leukemia ·Siddharth Kunte, Lisa Rybicki, Auro Viswabandya, Roni Tamari, Asad Bashey, Alla Keyzner, Madiha Iqbal, Michael R. Grunwald, Bhagirathbhai Dholaria, Hany Elmariah, (unknown), Anurag K. Singh, Sameem Abedin, Amy E. DeZern, Richard J. Jones, Vikas Gupta, Aaron T. Gerds, Tania Jain	20
9	In vitro induction of neoantigen-specific T cells in myelodysplastic syndrome, a disease with low mutational burden 2020 ·Cytotherapy ·(unknown), Alison Tarke, (unknown), Luca Ferrari, (unknown), Franco Ferrari, Zeynep Koşaloğlu, Alessandro Sette, Bjoern Peters, (unknown), Asad Bashey, Dimitrios Tzachanis, Edward D. Ball, Tiffany Tanaka, Rafael Bejar, Thomas A. Lane, Antonella Vitiello	8
10	HLA-haploidentical vs matched-sibling hematopoietic cell transplantation: a systematic review and meta-analysis 2019 ·Blood Advances ·Mohamad Aghaie Meybodi, Wenhao Cao, Leo Luznik, Asad Bashey, Xu Zhang, Rizwan Romee, Wael Saber, Mehdi Hamadani, Daniel J. Weisdorf, Haitao Chu, Armin Rashidi	28
11	Phase II Study Evaluating the Safety and Efficacy of BL-8040 for the Mobilization of Donor Hematopoietic Stem and Progenitor Cells for Allogeneic Hematopoietic Cell Transplantation and Phenotypic Characterization of the Leukapheresis Product 2018 ·Blood ·Michael P. Rettig, Geoffrey L. Uy, Asad Bashey, Steven M. Devine, Samantha Jaglowski, (unknown), Ella Sorani, (unknown), Osnat Bohana‐Kashtan, Stephen Shaw, Peter Westervelt, John F. DiPersio	1
12	Factors Predicting Graft-versus-Host Disease–Free, Relapse-Free Survival after Allogeneic Hematopoietic Cell Transplantation: Multivariable Analysis from a Single Center 2016 ·Biology of Blood and Marrow Transplantation ·Melhem Solh, Xu Zhang, (unknown), Stacey Brown, Scott R. Solomon, Lawrence E. Morris, H. Kent Holland, Asad Bashey	38
13	Calcineurin Inhibitor–Free Graft-versus-Host Disease Prophylaxis with Post-Transplantation Cyclophosphamide and Brief-Course Sirolimus Following Reduced-Intensity Peripheral Blood Stem Cell Transplantation 2014 ·Biology of Blood and Marrow Transplantation ·Scott R. Solomon, Melissa Sanacore, Xu Zhang, Stacey Brown, Kent Holland, Lawrence E. Morris, Asad Bashey	41
14	T-Cell–Replete HLA-Haploidentical Hematopoietic Transplantation for Hematologic Malignancies Using Post-Transplantation Cyclophosphamide Results in Outcomes Equivalent to Those of Contemporaneous HLA-Matched Related and Unrelated Donor Transplantation 2013 ·Journal of Clinical Oncology ·Asad Bashey, Xu Zhang, Connie A. Sizemore, Karen Manion, Stacey Brown, H. Kent Holland, Lawrence E. Morris, Scott R. Solomon	333
15	Myeloablative Conditioning With PBSC Grafts For T-Replete Haploidentical Donor Hematopoietic Cell Transplantation Using Post-Transplant Cyclophosphamide Results In Universal Engraftment, Low Rates Of Gvhd, NRM and Excellent Survival Outcomes: An Analysis Of Two Consecutive Phase II Studies From a Single Center 2013 ·Blood ·Scott R. Solomon, Stephanie Jacobson, (unknown), Melissa Sanacore, Xu Zhang, Connie A. Sizemore, (unknown), H. Kent Holland, Lawrence E. Morris, Asad Bashey	3
16	Haploidentical Transplantation Using T Cell Replete Peripheral Blood Stem Cells and Myeloablative Conditioning in Patients with High-Risk Hematologic Malignancies Who Lack Conventional Donors is Well Tolerated and Produces Excellent Relapse-Free Survival: Results of a Prospective Phase II Trial 2012 ·Biology of Blood and Marrow Transplantation ·Scott R. Solomon, Connie A. Sizemore, Melissa Sanacore, Xu Zhang, Stacey Brown, H. Kent Holland, Lawrence E. Morris, Asad Bashey	207
17	Outpatient myeloablative allo-SCT: a comprehensive approach yields decreased hospital utilization and low TRM 2009 ·Bone Marrow Transplantation ·Scott R. Solomon, (unknown), (unknown), Asad Bashey, Karen Manion, (unknown), (unknown), (unknown), Lawrence E. Morris, H. Kent Holland	31
18	Allogeneic hematopoietic cell transplantation for metastatic breast cancer 2007 ·Bone Marrow Transplantation ·Naoto T. Ueno, J. Douglas Rizzo, Taner Demirer, Yee Chung Cheng, Ute Hegenbart, M-J Zhang, Marco Bregni, Angelo Michele Carella, Didier Blaise, Asad Bashey, Jacob D. Bitran, Brian J. Bolwell, Gerald J. Elfenbein, (unknown), César O. Freytes, Robert Peter Gale, Hillard M. Lazarus, Richard E. Champlin, Patrick J. Stiff, Dietger Niederwieser	47
19	Phase I study of a neutralizing monoclonal anti-CTLA4 antibody (MDX-010) in patients with relapse of malignancy after allogeneic hematopoietic stem cell transplantation 2005 ·Biology of Blood and Marrow Transplantation ·Asad Bashey, Bridget Medina, (unknown), Jiehua Zhou, Ewa Carrier, Januario E. Castro, Peter Holman, T.A. Lane, Catherine Q. Sun, Israel Lowy, Sue Corringham, Robert J. Soiffer, James R. Mason, Edward D. Ball	2
20	Effect of nucleated marrow cell dose on relapse and survival in identical twin bone marrow transplants for leukemia. 2000 ·Blood ·A. John Barrett, Olle Ringdén, Mei‐Jie Zhang, Asad Bashey, Jean‐Yves Cahn, Mitchell S. Cairo, Robert Peter Gale, Aloïs Gratwohl, Franco Locatelli, Rodrigo Martino, Kirk R. Schultz, Pierre Tiberghien	66

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact